Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency

Anna Chiara Nascimbeni, Marina Fanin, Elisabetta Tasca, Corrado Angelini

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

OBJECTIVES: To examine at molecular, biochemical, and muscle pathology level the striking clinical heterogeneity resulting from acid α-glucosidase deficiency. METHODS: We investigated 23 patients with infantile-onset or late-onset glycogen storage disease type II by enzyme activity, protein expression by immunoblotting, GAA gene mutations, and muscle pathology including immunolabeling for Golgi and sarcolemmal proteins. RESULTS: The enzyme activity was absent or minimal in infantile-onset cases and variably reduced in late-onset patients. Genotype-phenotype correlation (seven novel mutations were found) showed that most late-onset patients had the heterozygous IVS1 leaky splicing mutation (one patient was homozygous), but the course of the disease was often difficult to predict on the basis of the mutations alone. All patients showed an abnormal pattern of enzyme protein processing, with increased amounts of the inactive forms and very low or absent amounts of the mature forms. The molecular weight of the mature and the intermediate forms appeared higher in patients' samples than in the control muscle. We observed a Golgi proliferation in muscle fibers possibly caused by the retention of inactive forms of enzyme protein that cannot be correctly targeted from Golgi to lysosomes. The vacuolar membranes expressed sarcolemmal proteins in late-onset but not in infantile-onset patients, suggesting an extensive autophagy and vacuolar membrane remodeling in late-onset patients. CONCLUSIONS: The different protein molecular weight between patients and controls could be due to an excessive sialylation of mutant enzyme: this might be possibly caused by a delayed transport and longer transit of the inactive proteins in the Golgi apparatus.

Original languageEnglish
Pages (from-to)617-626
Number of pages10
JournalNeurology
Volume70
Issue number8
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Glycogen Storage Disease Type II
Molecular Pathology
Phenotype
Enzymes
Proteins
Muscles
Mutation
Molecular Weight
Pathology
Glucosidases
Membranes
Autophagy
Genetic Association Studies
Golgi Apparatus
Lysosomes
Immunoblotting

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. / Nascimbeni, Anna Chiara; Fanin, Marina; Tasca, Elisabetta; Angelini, Corrado.

In: Neurology, Vol. 70, No. 8, 02.2008, p. 617-626.

Research output: Contribution to journalArticle

Nascimbeni, Anna Chiara ; Fanin, Marina ; Tasca, Elisabetta ; Angelini, Corrado. / Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. In: Neurology. 2008 ; Vol. 70, No. 8. pp. 617-626.
@article{b7ca56e08421494c9f00e883fed855f0,
title = "Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency",
abstract = "OBJECTIVES: To examine at molecular, biochemical, and muscle pathology level the striking clinical heterogeneity resulting from acid α-glucosidase deficiency. METHODS: We investigated 23 patients with infantile-onset or late-onset glycogen storage disease type II by enzyme activity, protein expression by immunoblotting, GAA gene mutations, and muscle pathology including immunolabeling for Golgi and sarcolemmal proteins. RESULTS: The enzyme activity was absent or minimal in infantile-onset cases and variably reduced in late-onset patients. Genotype-phenotype correlation (seven novel mutations were found) showed that most late-onset patients had the heterozygous IVS1 leaky splicing mutation (one patient was homozygous), but the course of the disease was often difficult to predict on the basis of the mutations alone. All patients showed an abnormal pattern of enzyme protein processing, with increased amounts of the inactive forms and very low or absent amounts of the mature forms. The molecular weight of the mature and the intermediate forms appeared higher in patients' samples than in the control muscle. We observed a Golgi proliferation in muscle fibers possibly caused by the retention of inactive forms of enzyme protein that cannot be correctly targeted from Golgi to lysosomes. The vacuolar membranes expressed sarcolemmal proteins in late-onset but not in infantile-onset patients, suggesting an extensive autophagy and vacuolar membrane remodeling in late-onset patients. CONCLUSIONS: The different protein molecular weight between patients and controls could be due to an excessive sialylation of mutant enzyme: this might be possibly caused by a delayed transport and longer transit of the inactive proteins in the Golgi apparatus.",
author = "Nascimbeni, {Anna Chiara} and Marina Fanin and Elisabetta Tasca and Corrado Angelini",
year = "2008",
month = "2",
doi = "10.1212/01.wnl.0000299892.81127.8e",
language = "English",
volume = "70",
pages = "617--626",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency

AU - Nascimbeni, Anna Chiara

AU - Fanin, Marina

AU - Tasca, Elisabetta

AU - Angelini, Corrado

PY - 2008/2

Y1 - 2008/2

N2 - OBJECTIVES: To examine at molecular, biochemical, and muscle pathology level the striking clinical heterogeneity resulting from acid α-glucosidase deficiency. METHODS: We investigated 23 patients with infantile-onset or late-onset glycogen storage disease type II by enzyme activity, protein expression by immunoblotting, GAA gene mutations, and muscle pathology including immunolabeling for Golgi and sarcolemmal proteins. RESULTS: The enzyme activity was absent or minimal in infantile-onset cases and variably reduced in late-onset patients. Genotype-phenotype correlation (seven novel mutations were found) showed that most late-onset patients had the heterozygous IVS1 leaky splicing mutation (one patient was homozygous), but the course of the disease was often difficult to predict on the basis of the mutations alone. All patients showed an abnormal pattern of enzyme protein processing, with increased amounts of the inactive forms and very low or absent amounts of the mature forms. The molecular weight of the mature and the intermediate forms appeared higher in patients' samples than in the control muscle. We observed a Golgi proliferation in muscle fibers possibly caused by the retention of inactive forms of enzyme protein that cannot be correctly targeted from Golgi to lysosomes. The vacuolar membranes expressed sarcolemmal proteins in late-onset but not in infantile-onset patients, suggesting an extensive autophagy and vacuolar membrane remodeling in late-onset patients. CONCLUSIONS: The different protein molecular weight between patients and controls could be due to an excessive sialylation of mutant enzyme: this might be possibly caused by a delayed transport and longer transit of the inactive proteins in the Golgi apparatus.

AB - OBJECTIVES: To examine at molecular, biochemical, and muscle pathology level the striking clinical heterogeneity resulting from acid α-glucosidase deficiency. METHODS: We investigated 23 patients with infantile-onset or late-onset glycogen storage disease type II by enzyme activity, protein expression by immunoblotting, GAA gene mutations, and muscle pathology including immunolabeling for Golgi and sarcolemmal proteins. RESULTS: The enzyme activity was absent or minimal in infantile-onset cases and variably reduced in late-onset patients. Genotype-phenotype correlation (seven novel mutations were found) showed that most late-onset patients had the heterozygous IVS1 leaky splicing mutation (one patient was homozygous), but the course of the disease was often difficult to predict on the basis of the mutations alone. All patients showed an abnormal pattern of enzyme protein processing, with increased amounts of the inactive forms and very low or absent amounts of the mature forms. The molecular weight of the mature and the intermediate forms appeared higher in patients' samples than in the control muscle. We observed a Golgi proliferation in muscle fibers possibly caused by the retention of inactive forms of enzyme protein that cannot be correctly targeted from Golgi to lysosomes. The vacuolar membranes expressed sarcolemmal proteins in late-onset but not in infantile-onset patients, suggesting an extensive autophagy and vacuolar membrane remodeling in late-onset patients. CONCLUSIONS: The different protein molecular weight between patients and controls could be due to an excessive sialylation of mutant enzyme: this might be possibly caused by a delayed transport and longer transit of the inactive proteins in the Golgi apparatus.

UR - http://www.scopus.com/inward/record.url?scp=39749132312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749132312&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000299892.81127.8e

DO - 10.1212/01.wnl.0000299892.81127.8e

M3 - Article

C2 - 18285536

AN - SCOPUS:39749132312

VL - 70

SP - 617

EP - 626

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -